Gulf Drug
Gulf Drug, officially known as Gulf Drug Establishment, is a prominent player in the pharmaceutical and healthcare industry, headquartered in the United Arab Emirates (AE). Founded in 1969, the company has established a strong presence across the Middle East, focusing on the distribution and marketing of a diverse range of pharmaceutical products, medical devices, and healthcare solutions. With a commitment to quality and innovation, Gulf Drug offers unique services such as cold chain logistics and regulatory support, ensuring the safe delivery of critical healthcare products. The company has achieved significant milestones, including partnerships with leading global pharmaceutical manufacturers, solidifying its market position as a trusted distributor in the region. Gulf Drug continues to enhance healthcare accessibility, making it a key contributor to the UAE's healthcare landscape.
DitchCarbon Score
How does Gulf Drug's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Gulf Drug's score of 5 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Gulf Drug's reported carbon emissions
Gulf Drug, headquartered in the United Arab Emirates, has made significant commitments towards reducing its carbon emissions, although specific emissions data for the most recent year is currently unavailable. The company has committed to achieving net-zero emissions across all scopes by 2050, aligning with the Science Based Targets initiative (SBTi). This long-term target reflects Gulf Drug's dedication to addressing climate change within the healthcare sector. As of 2023, Gulf Drug is actively working towards its net-zero goal, demonstrating a proactive approach to sustainability. The company is classified as "committed" to near-term targets, although specific reduction percentages have not been disclosed. This commitment underscores Gulf Drug's role in the healthcare providers and services sector, where reducing carbon footprints is increasingly critical. Overall, Gulf Drug's climate initiatives highlight its ambition to contribute positively to environmental sustainability while navigating the challenges of the healthcare industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Gulf Drug is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
